23 results
10-K/A
2023 FY
KRTX
Karuna Therapeutics Inc
14 Mar 24
Annual report (amended)
4:16pm
until 2018, serving in various roles of increasing authority during her tenure there, including Executive Vice President–Strategy and Commercial … Financial Officer of Tyco International from 2005 to 2010. During his tenure, he played a central role in the separation of Tyco into five independent
8-K
3gtq0rtl16sut
13 Aug 20
Karuna Therapeutics Appoints Laurie Olson to Board of Directors
6:33am
8-K
EX-99.1
o0uwzuk
13 Aug 20
Karuna Therapeutics Appoints Laurie Olson to Board of Directors
6:33am
DEF 14A
uquj nf008
29 Apr 20
Definitive proxy
4:00pm
8-K
8ls0kf i3b21ih2o0loc
28 Apr 20
Karuna Therapeutics Appoints Christopher J. Coughlin to its
6:13am
424B4
u8f5e0g gbmr
21 Nov 19
Prospectus supplement with pricing info
4:02pm
DRS
to9u07ru
28 Oct 19
Draft registration statement
12:00am
8-K
EX-3.2
slrzslg5ym5x6ix epg9
3 Jul 19
Karuna Therapeutics Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
12:00am
424B4
jaj733 ekib011jb82i
28 Jun 19
Prospectus supplement with pricing info
4:03pm
S-1
EX-3.4
1l27 2e9lq
31 May 19
IPO registration
4:03pm
S-1
t395 qph30qzbq
31 May 19
IPO registration
4:03pm
S-1
EX-3.2
nrh0l
31 May 19
IPO registration
4:03pm
DRS/A
wc0quk g52emtibif
22 May 19
Draft registration statement (amended)
12:00am
DRS/A
EX-3.2
qrxpsgb4px8p11c9b3d
2 May 19
Draft registration statement (amended)
12:00am